hrp0098p1-170 | Growth and Syndromes 2 | ESPE2024

Growth hormone therapy is not efficient in improving the adult height of children with Hypochondroplasia

Rosa Pellicciari Caroline , Silva Alves da Rocha Renata , Pieri Ribeiro Maine , Liberatoscioli Menezes de Andrade Nathalia , A. L. Jorge Alexander , C. Malaquias Alexsandra

Introduction: Hypochondroplasia (HCH) is a form of mild dwarfism caused by heterozygous gain-of-function mutations in the fibroblast growth factor receptor 3 (FGFR3). FGFR3 is a negative regulator of endochondral bone growth, and individuals with HCH typically exhibit characteristics such as disproportionate short stature with shortening limb length, lumbar lordosis, and macrocephaly. Regarding recombinant human growth hormone (rhGH) therapy in children with H...